What makes your innovation unique?
myBioma is a health platform for analysing the gut microbiome using stool samples. It utilises next-generation sequencing, AI and bioinformatics to detect early signs of disease, monitor health conditions and offer personalised recommendations for gut health and wellbeing.
Advantages
• The system is able to detect diseases (e.g. cancer) at an early stage.
• It offers personalised recommendations for health promotion.
• It enables precise analyses using state-of-the-art technologies.
Awards
• EIT Catapult Winner – 2023
• Born Global Champions – 2023
• Web Summit Audience Award – 2022
• EY Scale-up Award – 2022
About the company
Biome Diagnostics (BiomeDx), an Austrian med-tech company, has been developing microbiome-based technologies since 2018. Using DNA sequencing and AI, it is revolutionising precision medicine, particularly in cancer treatment and integrating it into clinical routine.
